Paradigm BioCapital Advisors LP 13D and 13G filings for Arcellx, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:35 pm Purchase |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 4,800,000 8.900% |
1,141,376 (+31.20%) |
Filing |
| 2024-02-14 5:57 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 3,658,624 7.000% |
1,235,924 (+51.01%) |
Filing |
| 2023-07-21 4:44 pm Purchase |
2023-07-11 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 2,422,700 5.050% |
2,422,700 (New Position) |
Filing |